Introduction

The New York Rangers entered the season with hopes of making a splash in the historic 2026 free agent class. However, with many top players like Connor McDavid and Jack Eichel extending their contracts, the Rangers now find themselves at a crossroads with one of their most valuable assets, Artemi Panarin.

Current Situation

Artemi Panarin's seven-year contract, signed in 2019, is set to expire on July 1, putting the Rangers in a precarious situation. As the team ages and showcases stagnation in their performance, questions arise: Is trading their leading scorer the answer to revitalizing the roster? Panarin's declining production has raised eyebrows, as he has only managed 36 points over 37 games this season—a stark contrast to his 120-point season two years ago.

Impact on the Team

Despite his subpar point total, Panarin's on-ice presence remains crucial for the Rangers. With a goals-per-60 rate of 3.15 while on the ice, he significantly boosts the team's scoring. This fact becomes even more evident as the Rangers struggle offensively, ranking as the second-lowest scoring team at even strength in the NHL.

Future Considerations

The Rangers must now consider significant roster changes. Re-signing Panarin will require navigating complex negotiations, including his potential demands for both contract term and annual value. Estimates suggest a hypothetical contract valued at three years and $33 million could allow Panarin to remain, although his future performance remains uncertain. The Rangers could face a tough decision: hold on to him or risk losing him for nothing at the trade deadline.

The Trade Dilemma

If the Rangers opt not to re-sign Panarin by the March 6 trade deadline, they may have to trade him. However, given Panarin's no-trade clause, the team's options could be limited. Concerns arise about what return they might receive in a trade, especially if Panarin actively chooses his destination.

Potential Outcomes

Ultimately, the Rangers find themselves in a challenging position. While keeping Panarin might lead to future overpayments, the alternative could plunge the team into further irrelevance. The prospect of bringing in an elite player hinges on maintaining a competitive roster—one that currently revolves around Panarin's offensive creativity. The Rangers are in a delicate balance, weighing short-term needs against long-term aspirations.

Conclusion

Decisions regarding Artemi Panarin will define the direction of the Rangers moving forward. The team is at a significant juncture, and their choices in the coming months will likely influence their competitiveness in the NHL for years to come.